| Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net (loss) income | 15 | -248 | -305 |
|---|
| Depreciation and amortization of intangible assets | 379 | 382 | 436 |
|---|
| Amortization of Debt Issuance Costs and Discounts | 8 | 30 | 20 |
|---|
| Asset impairments | 1 | - | 5 |
|---|
| Allowances for losses on trade receivables and inventories | 25 | 21 | 26 |
|---|
| Deferred income taxes | -90 | -10 | -10 |
|---|
| Gain on sale of assets | - | - | 5 |
|---|
| Share-based compensation | 62 | 74 | 92 |
|---|
| Foreign exchange gain (loss) | 7 | -12 | -10 |
|---|
| Gain excluded from hedge effectiveness | 6 | 13 | 13 |
|---|
| Amortization, Interim Contract And Inventory Step From Acquisition | - | 23 | 82 |
|---|
| Other | 19 | 3 | 19 |
|---|
| Trade receivables | 95 | 121 | 227 |
|---|
| Inventories | 106 | 264 | 147 |
|---|
| Prepaid expenses and other current assets | 7 | 147 | -161 |
|---|
| Accounts payable, accrued and other liabilities | 189 | 245 | 126 |
|---|
| Net cash provided by (used in) operating activities | 345 | -17 | 232 |
|---|
| Acquisitions and other investments | 45 | 1,941 | 138 |
|---|
| Purchases of property, plant and equipment | 175 | 181 | 291 |
|---|
| Purchases of marketable securities | 17 | 17 | 12 |
|---|
| Proceeds from sale of marketable securities | 22 | 16 | 14 |
|---|
| Proceeds from Divestiture of Businesses, Net of Cash Divested | - | 1 | 2 |
|---|
| Interest settlements from cross-currency swaps | - | 13 | 13 |
|---|
| Net cash used in investing activities | -215 | -2,109 | -412 |
|---|
| Proceeds from Issuance of Long-Term Debt | 2,440 | 2,276 | 631 |
|---|
| Repayments of debt | 13 | 161 | 430 |
|---|
| Payment of employee withholding taxes related to share-based awards | - | 10 | 12 |
|---|
| Payments of financing costs | 3 | 16 | - |
|---|
| Payments of noncontrolling interest distributions | 11 | 9 | 10 |
|---|
| Net Borrowings, Financing Activities | 31 | - | - |
|---|
| Net transfers to BHC (Note 3) | 2,363 | - | - |
|---|
| Other | - | -2 | -1 |
|---|
| Net cash provided by financing activities | 81 | 2,078 | 178 |
|---|
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -8 | 2 | -16 |
|---|
| Net (decrease) increase in cash and cash equivalents and restricted cash | 203 | -46 | -18 |
|---|
| Capital Expenditures Incurred but Not yet Paid | - | 65 | 56 |
|---|
| Notes Issued | 2,200 | - | - |
|---|